Synopsys, Inc. $SNPS Shares Purchased by PGGM Investments

PGGM Investments raised its position in Synopsys, Inc. (NASDAQ:SNPSFree Report) by 5.4% during the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 140,654 shares of the semiconductor company’s stock after purchasing an additional 7,260 shares during the quarter. PGGM Investments owned 0.08% of Synopsys worth $69,397,000 as of its most recent SEC filing.

A number of other large investors also recently added to or reduced their stakes in SNPS. Alpine Bank Wealth Management raised its holdings in shares of Synopsys by 89.3% in the 3rd quarter. Alpine Bank Wealth Management now owns 53 shares of the semiconductor company’s stock valued at $26,000 after buying an additional 25 shares during the period. TFC Financial Management Inc. boosted its holdings in Synopsys by 1,250.0% during the 3rd quarter. TFC Financial Management Inc. now owns 54 shares of the semiconductor company’s stock valued at $27,000 after acquiring an additional 50 shares during the period. Independence Bank of Kentucky grew its position in Synopsys by 120.0% in the 2nd quarter. Independence Bank of Kentucky now owns 55 shares of the semiconductor company’s stock valued at $28,000 after acquiring an additional 30 shares in the last quarter. SOA Wealth Advisors LLC. purchased a new stake in Synopsys during the third quarter worth about $28,000. Finally, McIlrath & Eck LLC acquired a new stake in shares of Synopsys during the third quarter worth about $29,000. 85.47% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity

In related news, CFO Shelagh Glaser sold 3,657 shares of the company’s stock in a transaction that occurred on Friday, December 19th. The stock was sold at an average price of $460.77, for a total value of $1,685,035.89. Following the completion of the transaction, the chief financial officer directly owned 17,842 shares of the company’s stock, valued at $8,221,058.34. This represents a 17.01% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, insider Janet Lee sold 250 shares of the stock in a transaction that occurred on Monday, January 12th. The shares were sold at an average price of $530.00, for a total transaction of $132,500.00. Following the completion of the transaction, the insider owned 11,959 shares in the company, valued at $6,338,270. This represents a 2.05% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders have sold a total of 4,157 shares of company stock worth $1,945,036 in the last three months. Corporate insiders own 0.62% of the company’s stock.

Synopsys Price Performance

Synopsys stock opened at $508.19 on Friday. The company has a current ratio of 1.62, a quick ratio of 1.52 and a debt-to-equity ratio of 0.48. The company has a fifty day simple moving average of $452.89 and a 200-day simple moving average of $505.04. The stock has a market cap of $97.23 billion, a P/E ratio of 63.60, a price-to-earnings-growth ratio of 4.21 and a beta of 1.12. Synopsys, Inc. has a 12-month low of $365.74 and a 12-month high of $651.73.

Synopsys (NASDAQ:SNPSGet Free Report) last posted its earnings results on Wednesday, December 10th. The semiconductor company reported $2.90 EPS for the quarter, beating the consensus estimate of $2.79 by $0.11. The firm had revenue of $2.25 billion for the quarter, compared to analyst estimates of $2.25 billion. Synopsys had a return on equity of 7.89% and a net margin of 18.89%.Synopsys’s revenue for the quarter was up 37.8% compared to the same quarter last year. During the same quarter in the prior year, the company posted $3.40 earnings per share. Synopsys has set its FY 2026 guidance at 14.320-14.400 EPS and its Q1 2026 guidance at 3.520-3.580 EPS. Equities analysts expect that Synopsys, Inc. will post 10.64 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of brokerages recently weighed in on SNPS. Wall Street Zen upgraded shares of Synopsys from a “sell” rating to a “hold” rating in a report on Saturday, December 13th. Bank of America raised shares of Synopsys from an “underperform” rating to a “neutral” rating and decreased their price target for the company from $525.00 to $500.00 in a research report on Monday, December 8th. Zacks Research raised Synopsys from a “strong sell” rating to a “hold” rating in a research report on Monday, November 10th. Needham & Company LLC increased their price objective on Synopsys from $550.00 to $580.00 and gave the company a “buy” rating in a research note on Thursday, December 11th. Finally, BNP Paribas initiated coverage on Synopsys in a research note on Thursday, October 2nd. They set an “underperform” rating and a $425.00 target price for the company. Nine investment analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat, the company presently has an average rating of “Hold” and an average price target of $553.57.

View Our Latest Stock Report on SNPS

About Synopsys

(Free Report)

Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.

In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.

Further Reading

Institutional Ownership by Quarter for Synopsys (NASDAQ:SNPS)

Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.